Neupath Health Inc. (NPTH) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neupath Health Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.779 joining us this morning for New Paths Q3 results. 00:00:05.779 -- 00:00:09.003 The company will be making a presentation 00:00:09.003 -- 00:00:14.130 and discussing their business and their financial results. 00:00:14.130 -- 00:00:18.256 And then we will be taking questions from the audience. 00:00:18.256 -- 00:00:23.082 So please type your questions into the Zoom Q&A. 00:00:23.082 -- 00:00:27.871 function, and I will read those out to management. 00:00:27.871 -- 00:00:31.577 Please try to keep the questions clear and tight. 00:00:31.577 -- 00:00:36.807 It makes everything a lot better. Sometimes it's literally hard to understand what 00:00:36.807 -- 00:00:38.991 the question is. 00:00:38.991 -- 00:00:44.100 And with that, we're gonna get the show officially on the 00:00:44.100 -- 00:00:46.117 go here. 00:00:46.117 -- 00:00:51.683 NewPath is Canada's largest provider of health care services for the treatment and assessment 00:00:51.683 -- 00:00:56.409 of chronic pain, back injuries, sports-related injuries, and concussions. 00:00:56.409 -- 00:01:01.515 The company just released its Q3 results with over 26% revenue 00:01:01.515 -- 00:01:06.881 growth and adjusted EBITDA up 98%. CEO Joe Wolowitz 00:01:06.881 -- 00:01:10.505 and Stephen Lemieux, the president, are here to discuss the results. 00:01:10.505 -- 00:01:12.728 I'm Martin Gagel with Market Radius Research. 00:01:12.728 -- 00:01:16.817 Please remember, this is neither a recommendation nor investment advice. 00:01:16.817 -- 00:01:21.528 Gentlemen, welcome back and congrats on another strong quarter. 00:01:21.528 -- 00:01:24.214 Thanks, Martin, and thanks for the intro there. 00:01:24.214 -- 00:01:27.622 I'm Joe Wolowitz. I'm the CEO of New Path Health, and I'm joined here by S...